Gamida Cell Ltd (GMDA) Stock
GMDA is no longer traded. Gamida Cell was delisted from the Nasdaq in April 2024.
Prices on this page are historical; the last trade was April 26, 2024 at $0.02.
Gamida Cell stock price history
GMDA final trading statistics
- Final close
- $0.02
- Final trading day
- Apr 26, 2024
- Market cap at delisting
- $2.44M
- Shares outstanding
- 132.64M
- Final 52-week range
- $0.01 – $2.51
- Avg. volume (final 3 mo.)
- 9,348,687
- All-time high (split-adj.)
- $15.41 · Nov 2018
- All-time low (split-adj.)
- $0.01 · Apr 2024
- Return since IPO
- -99.8%
- Beta
- 1.03
- Book value / share
- $0.00
- Price / book
- 6.13
Gamida Cell annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | $1.78M | -$63.0M | -$0.63 |
| FY2022 | $0.00 | -$154.4M | -$1.24 |
| FY2021 | $0.00 | -$92.4M | -$1.52 |
| FY2020 | $0.00 | -$76.4M | -$1.62 |
| FY2019 | $0.00 | -$34.4M | -$1.00 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Gamida Cell Ltd
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with hematologic malignancies, as well as in Phase II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, an investigational NK cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was incorporated in 1998 and is headquartered in Jerusalem, Israel.
Gamida Cell stock FAQ
What happened to Gamida Cell stock?
Gamida Cell stock was delisted from the Nasdaq. Its final close was $0.02 on April 26, 2024.
Is GMDA stock still trading?
No. GMDA was delisted from the Nasdaq in April 2024 and no longer trades on a U.S. exchange.
What was the last price of GMDA stock?
GMDA closed at $0.02 on its final trading day, April 26, 2024, for a market value of about $2.44M.
What were Gamida Cell's revenue and earnings in its last full fiscal year?
Gamida Cell reported revenue of $1.78M and net income of -$63.0M in fiscal 2023, its last full year as a public company.
When did Gamida Cell go public?
Gamida Cell Ltd stock began trading on October 26, 2018.